Regorafenib, ≥98%

Catalog No. 460712

General Information

Synonyms	BAY 73-4506
CAS No.	755037-03-7
M.F.	C₂₁H₁₅ClF₄N₄O₃
M.W.	482.82

Technical Data

Assay	≥98%
Solubility	DMSO >90 mg/ml (25℃)
Storage	-20℃
Description	Regorafenib is an oral multi-kinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinase. Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.

Reference

Cyran CC, et al. PLoS One. 2013 Sep 30;8(9):e76009
André T, et al. Bull Cancer. 2013 Oct 1;100(10):1027-1029
Adenis A, et al. Acta Oncol. 2013 Nov;52(8):1789-90
Wilhelm SM, et al. Int J Cancer. 2011 Jul 1;129(1):245-55

Size	Price	Quantity	Favorites
50 mg	USD150
200 mg	USD420

Please inquire for non-standard packs and bulk quantities.

Availability: Ships in 1-3 days

For research use only. Not for human use.

> Certificate of Analysis

> MSDS

	(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject	460712, Regorafenib, ≥98%, 755037-03-7
*Message
*Code

Regorafenib, ≥98%

Inquire